Pohlmann PR, Graham D, Wu T, Ottaviano Y, et al. HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane. Breast Cancer Res Treat 2022 Oct 25. pii: 10.1007/s10549-022-06743.
PMID: 36280642